What is the impact of coronavirus on the cannabis industry?

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

What is the impact of coronavirus on the cannabis industry?

Sponsored by

daniel-400px.png
Bush marijuana cannabis on blurred background at sunset.

Amid the massive public health crisis caused by the fear of the spread of COVID-19, economies and societies around the world are facing hardship, with entire businesses brought to a sudden halt.

It is difficult to predict what markets will look like in the foreseeable future, while many companies are assessing how to survive in the “coronavirus economy." We have decided to take a quick look at the highly regulated but promising cannabis market in Brazil. 

Except for extremely particular circumstances, the commercialisation of cannabis-based products was not allowed (since January 2015, it has been possible to import medical oil and extract products with cannabis active principles [CBD], but only with authorisation by the Brazilian Health Surveillance Agency "ANVISA"). In December 2019, however, the ANVISA approved the rules to regularise medicinal products that contain cannabis for medical purposes.

Politically, the decision favouring cannabis products was quite surprising given the sitting conservative government. That was all the more reason, however, to fuel discussion on the prospects of further developing the cannabis market in the largest economy and consumer market in Latin America.

That said, what does the coronavirus pandemic mean for the cannabis market in Brazil?

With the limitations imposed by the virus, businesses that still have room to invest are diverting from traditional marketing and sales campaigns. Instead, they are looking at innovative ways to interact with consumers, focusing on brand development strategies with strong supportive messages for when the market picks up.

That strategy is valid for existing businesses in Brazil, but also those looking at entering the market. Proper branding strategies will be an advantage in the post-lockdown world and allow businesses to reap the rewards in the future. Indeed, this may be relevant for cannabis-based businesses that wish to explore the promising Brazilian market.

One of the clearer ones seems that of setting a trademark foothold. That means securing cannabis-related trademark registrations well before the register becomes overpopulated with cannabis-related terms.

The Brazilian Patent and Trademark Office (BPTO) does not require prior use of a mark to grant a registration. Therefore, cannabis brands won't be barred by such a threshold. A trademark only becomes vulnerable to cancellation based on non-use after five years counted from the registration's grant. Even then, non-use actions must be initiated by interested parties based on "legitimate reasons."

More importantly, however, is that Brazil adopts the first-to-file principle. Almost quite literally, those who arrive first will have a clearer path to registration at the BPTO as far as relative grounds go.

While we are not advocating in favour of opportunistic filers, securing early trademark rights can undoubtedly benefit brands interested in exploring the growing Brazilian cannabis market.

As a precautionary measure, the BPTO has suspended deadlines. Nonetheless, it is operating normally, publishing notices, and examining cases. Therefore, for those looking to invest in the developing cannabis market, it may be an opportune moment for securing trademark protection for your cannabis products and services. The BPTO applies rather rigid relative grounds examinations – even if no opposition is filed –  and it is fair to assume it will be an advantage to prosecute cannabis-related brands before the register becomes overpopulated.

Of course, there are other important aspects involved in the prosecution of these trademarks that applicants should discuss with local counsel. For example, in some instances, the BPTO could raise absolute grounds as a basis for rejection (moral grounds can still be applicable in Brazil). There are also strategies to consider involving the specification of goods.

While the world still faces challenging times up ahead, we hope to see innovation and creativity that is capable of comforting people and fostering businesses. Hopefully, we will also see more and more progress in legally rigid markets, such as that of cannabis-based products.


more from across site and SHARED ros bottom lb

More from across our site

The chief technology officer remit, which has been created as the firm is building its litigation team, will include expanding the use of AI in patent and legal work and automating manual processes
Former Hoyng Rokh Moneiger partner Laura Alonso, who brought her team to ECIJA in March, discusses plans to expand further and why ECIJA’s ‘IP DNA’ is helping broaden her work
Amita Haylock discusses building an integrated Asia practice as clients increasingly demand that firms combine IP, technology and data expertise
François Pochart, Grégoire Desrousseaux and Lionel Martin, long-standing figures in the firm’s patent litigation team, are set to help launch a Paris-based litigation offering
The Unitary Patent has passed 100,000 registrations, but new data raises the question of whether 30% uptake is a ceiling or a staging post for further growth, say Michael Nielsen and Darren Smyth of EIP and Andrew Samm at Patently
The new generation of in-house IP leaders want commercial judgment, accessibility and flexibility, with AI raising expectations around both fees and delivery
The firm launched a San Diego office earlier this month, but California investment and expansion is far from complete
The industry’s response to AI requires an unfamiliar ingredient as firms battle to shape their futures
The firm is looking beyond replacing recently departed talent, betting instead on senior leaders to strengthen and expand its patent litigation platform
Olga Partington, director in Sterne Kessler’s biotechnology and chemical practice group, shares why a patent's vulnerability peaks when it is young, rather than when it is most valuable, under the PTAB's new framework
Gift this article